Toxicity from cancer therapies greater in women: study

Sex differences should be factored in when considering treatment options, researchers suggest
Reuters Health

Women experience more symptomatic and haematologic adverse events from cancer treatments than men, especially from immunotherapy, a retrospective analysis has found.

Although between-sex differences in chemotherapy toxicity have been demonstrated in the past, the US researchers said there had been a gap in the literature regarding modern treatments.